statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business...

Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

Theravance Biopharma to Participate in an Upcoming Investor Conference Theravance Biopharma to Participate in an Upcoming Investor Conference PR Newswire DUBLIN, May 9, 2024 DUBLIN, May 9, 2024...

Theravance Biopharma to Participate in an Upcoming Investor Conference

Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024 Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024 PR Newswire DUBLIN, April 29...

Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024

Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients...

Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy (MSA) on May 23, 2024

This is a signal that TBPH's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...

Theravance Biopharma (TBPH, $9.02) Stochastic Oscillator left the overbought zone on April 01, 2024

This price move could indicate a change in the trend, and may be a buy signal for investors...

Theravance Biopharma (TBPH, $9.02) price moved above its 50-day Moving Average on April 01, 2024

This indicator may be signaling TBPH's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

Theravance Biopharma (TBPH, $8.85) entered Uptrend as Momentum indicator ascends above 0 level on Mar 19, 2024

This is a Bullish indicator signaling TBPH's price could rise from here. Traders may explore going long the stock or buying call options...

Theravance Biopharma (TBPH, $8.85) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 19, 2024

Theravance Biopharma, Inc. (NASDAQ:TBPH  Free Report)  Investment analysts at Zacks Research issued their FY2026 earnings estimates for shares of Theravance Biopharma in a note issued...

Theravance Biopharma, Inc. (NASDAQ:TBPH) Expected to Earn FY2026 Earnings of $0.75 Per Share

This is a Bearish indicator signaling TBPH's price could decline from here. Traders may explore shorting the stock or put options...

Theravance Biopharma (TBPH, $8.6) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 8, 2024

Theravance Biopharma, Inc. is a biopharmaceutical company, which engages in the discovery, research, development, and commercialization of respiratory medicines. It operates through the U.S. and Europe geographical segments. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand, and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.

Watchers	1,032
52-Wk Low	$8.21
52-Wk High	$11.71

Volume	1.00
52-Wk High	$11.71
52-Wk Low	$8.21

Period	Estimated	Reported	Surprise	Result
Q2'24	-$0.21	--	--	N/A
Q1'24	-$0.25	-$0.24	4.95%	BEAT
Q4'23	-$0.15	-$0.17	-15.25%	MISSED
Q3'23	-$0.21	-$0.17	19.05%	BEAT
Q2'23	-$0.21	-$0.28	-33.33%	MISSED

TBPH Theravance Biopharma Inc

About

Feed

News

Sentiment

Earnings

Fundamentals